Systemic therapy strategies for elderly patients with gastric cancer
Gastric cancer (GC) is the fifth most common malignancy and a leading cause of cancer mortality globally, with particularly high rates in East Asia. The median age at diagnosis is approximately 68 years, and over half of the cases occur in patients aged >65 years. As the life expectancy increases...
Saved in:
| Main Authors: | Yukiya Narita, Kei Muro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359251363057 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of nivolumab monotherapy infusion time-of-day on short- and long-term outcomes in patients with metastatic gastric cancer
by: Yasunobu Ishizuka, et al.
Published: (2025-05-01) -
Practical management of oligometastatic gastric cancer
by: Y. Narita, et al.
Published: (2024-12-01) -
Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study)
by: Naoki Takahashi, et al.
Published: (2024-11-01) -
Relationship between programmed cell death ligand 1 expression and the number of biopsy specimens in advanced gastric cancer
by: Taro Mizuno, et al.
Published: (2025-07-01) -
DNA nanotechnology-based strategies for gastric cancer diagnosis and therapy
by: Congcong Li, et al.
Published: (2025-02-01)